FDA cuts off use for AstraZeneca’s Covid-19 therapy Evusheld

The FDA has stopped use of an­oth­er drug as a re­sult of the new coro­n­avirus vari­ants. On Thurs­day, the agency an­nounced that As­traZeneca’s an­ti­body com­bo Evusheld, which was an im­por­tant pre­ven­tion op­tion for many im­muno­com­pro­mised peo­ple and oth­ers, is no longer…

#fda #evusheld #eli #regeneron #paxlovid #gilead #merck #elilillys